Meredith Kaya | Director, Investor Relations |
Peter Hecht | CEO |
Gina Consylman | SVP and CFO |
Thomas McCourt | CCO and SVP, Marketing and Sales |
Bill Huyett | COO |
Mark Currie | SVP, CSO, and President of R&D |
Christopher Wright | SVP, Global Development and CDO |
Divya Harikesh | Goldman Sachs |
Timothy Chiang | BTIG |
Vamil Divan | Credit Suisse |
Unidentified Analyst | Wells Fargo |
Boris Peaker | Cowen and Company |
Unidentified Analyst | Bank of America Merrill Lynch |
Unidentified Analyst | Morgan Stanley |
Geoff Meacham | Barclays |
Anupam Rama | J.P. Morgan |
Good day, ladies and gentlemen, and welcome to the Ironwood Pharmaceuticals Fourth Quarter 2017 Investor Update Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference is being recorded.